Anzu Partners — 2020 Investments
2 investments dated 2020 · listed companies and verified rows first · show all
BiotechRio Rancho, US
Alexander Koglin(Executive Officer, Director, Promoter)James Coffin(Executive Officer, Director)Michael Humbert(Executive Officer, Director, Promoter)
BoardPeter Kolchinsky(Director)inEdward Liddy(Director)
Board seatDavid Seldin· per SEC Form D
Co-investorsBlueStone Venture PartnersRA Capital
CAR-Macrophage cellular therapeutics with initial oncology focus (NASDAQ: CARM).
BiotechPhiladelphia, US
Steven Kelly(Executive Officer, Director)
BoardMargarita Chavez(Director)Eran Nadav(Director)Althea Stillman(Director)Jacob Gunterberg(Director)Regina Hodits(Director)
Co-investorsAju IB Invesment CorporationGrazia Equity GmbHHealthCapMRL Ventures FundSolasta VenturesAgent Capital+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.